Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benny J Evison

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 10, 2009
In vitro transcription assay for resolution of drug-DNA interactions at defined DNA sequencesBenny J Evison, Don R Phillips, Suzanne M Cutts
Molecular Pharmacology|April 17, 2008
Formaldehyde-activated Pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doubletsBenny J Evison, Francis Chiu, Gabriella Pezzoni, et al.
Nanotechnology, Science and Applications|December 31, 2015
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicinMas Jaffri Masarudin, Suzanne M Cutts, Benny J Evison, et al.
Medicinal Research Reviews|August 20, 2015
Mitoxantrone, More than Just Another Topoisomerase II PoisonBenny J Evison, Brad E Sleebs, Keith G Watson, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Design, synthesis, and DNA sequence selectivity of formaldehyde-mediated DNA-adducts of the novel N-(4-aminobutyl) acridine-4-carboxamideElizabeth A Ankers, Benny J Evison, Don R Phillips, et al.
Cancer Chemotherapy and Pharmacology|April 23, 2022
An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cellsOula C Mansour, Abraham Nudelman, Ada Rephaeli, et al.
Organic & Biomolecular Chemistry|September 25, 2010
DNA binding by pixantroneNajia Adnan, Damian P Buck, Benny J Evison, et al.
Nucleic Acids Research|September 2, 2009
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivityBenny J Evison, Rebecca A Bilardi, Francis C K Chiu, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2021
Development of an automated assay for accelerated in vitro detection of DNA adduct-inducing and crosslinking agentsJelena Medan, Brad E Sleebs, Kurt Lackovic, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2012
The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adductsRobert A Forrest, Lonnie P Swift, Benny J Evison, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|December 10, 2009
In vitro transcription assay for resolution of drug-DNA interactions at defined DNA sequencesBenny J Evison, Don R Phillips, Suzanne M Cutts
Molecular Pharmacology|April 17, 2008
Formaldehyde-activated Pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doubletsBenny J Evison, Francis Chiu, Gabriella Pezzoni, et al.
Nanotechnology, Science and Applications|December 31, 2015
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicinMas Jaffri Masarudin, Suzanne M Cutts, Benny J Evison, et al.
Medicinal Research Reviews|August 20, 2015
Mitoxantrone, More than Just Another Topoisomerase II PoisonBenny J Evison, Brad E Sleebs, Keith G Watson, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Design, synthesis, and DNA sequence selectivity of formaldehyde-mediated DNA-adducts of the novel N-(4-aminobutyl) acridine-4-carboxamideElizabeth A Ankers, Benny J Evison, Don R Phillips, et al.
Cancer Chemotherapy and Pharmacology|April 23, 2022
An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cellsOula C Mansour, Abraham Nudelman, Ada Rephaeli, et al.
Organic & Biomolecular Chemistry|September 25, 2010
DNA binding by pixantroneNajia Adnan, Damian P Buck, Benny J Evison, et al.
Nucleic Acids Research|September 2, 2009
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivityBenny J Evison, Rebecca A Bilardi, Francis C K Chiu, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2021
Development of an automated assay for accelerated in vitro detection of DNA adduct-inducing and crosslinking agentsJelena Medan, Brad E Sleebs, Kurt Lackovic, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2012
The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adductsRobert A Forrest, Lonnie P Swift, Benny J Evison, et al.
Pageof 2